Codexis (CDXS) EBT Margin Growth (1y) (2011 - 2026)
Codexis (CDXS) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 546.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4,709.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,076.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1,911.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2,507.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,565.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -392.00 |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | 610.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 610.00 |
| Mar 31, 2026 | 21,727.00 |
| Dec 31, 2025 | 7,305.00 |
| Sep 30, 2025 | -6,720.00 |
| Jun 30, 2025 | 19,854.00 |
| Mar 31, 2025 | -20,679.00 |
| Dec 31, 2024 | 9,480.00 |
| Sep 30, 2024 | 21,543.00 |
| Jun 30, 2024 | -5,478.00 |
| Mar 31, 2024 | 10,677.00 |
| Dec 31, 2023 | -8,025.00 |
| Sep 30, 2023 | -34,722.00 |
| Jun 30, 2023 | -22,369.00 |
| Mar 31, 2023 | -15,048.00 |
| Dec 31, 2022 | -2,158.00 |
| Sep 30, 2022 | -3,537.00 |
| Jun 30, 2022 | 1,013.00 |
| Mar 31, 2022 | 2,666.00 |
| Dec 31, 2021 | -2,271.00 |
| Sep 30, 2021 | 3,945.00 |